Hereditary Angioedema.
暂无分享,去创建一个
[1] S. Cichon,et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. , 2006, American journal of human genetics.
[2] A. Davis. Mechanism of angioedema in first complement component inhibitor deficiency. , 2006, Immunology and allergy clinics of North America.
[3] N. Monnier,et al. Characterisation of a new C1 inhibitor mutant in a patient with hepatocellular carcinoma. , 2006, Molecular immunology.
[4] K. Bork,et al. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. , 2006, Biochemical and biophysical research communications.
[5] K. Bork,et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.
[6] L. Romics,et al. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. , 2005, The Journal of allergy and clinical immunology.
[7] M. López-Trascasa,et al. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[8] M. Gompels,et al. C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.
[9] A. Tordai,et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.
[10] J. Church. Oxandrolone treatment of childhood hereditary angioedema. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[11] M. Cicardi,et al. How do we treat patients with hereditary angioedema. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[12] A. Davis,et al. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. , 2002, The Journal of clinical investigation.
[13] W. Tremaine,et al. Hereditary angioedema: a broad review for clinicians. , 2001, Archives of internal medicine.
[14] S. Choquet,et al. Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. , 2000, The Journal of allergy and clinical immunology.
[15] K. Binkley,et al. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. , 2000, The Journal of allergy and clinical immunology.
[16] K. Bork,et al. Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.
[17] K. Bork,et al. Hepatocellular adenomas in patients taking danazol for here ditary angiooedema , 1999, The Lancet.
[18] F. Rosen,et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema , 1998, Transfusion.
[19] F. Rosen,et al. Molecular defects in hereditary angioneurotic edema. , 1997, Proceedings of the Association of American Physicians.
[20] H. Bürgi,et al. Type I hereditary angio‐oedema. Variability of clinical presentation and course within two large kindreds , 1997, Journal of internal medicine.
[21] E. Verpy,et al. Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. , 1996, American journal of human genetics.
[22] F. Rosen,et al. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. , 1996, The New England journal of medicine.
[23] M. Cicardi,et al. Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.
[24] G. Tsokos,et al. Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. , 1986, The Journal of allergy and clinical immunology.
[25] M. Frank. Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema. , 1979, Arthritis and rheumatism.
[26] J. Atkinson,et al. Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.
[27] D. Alling,et al. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.
[28] J. Atkinson,et al. Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. , 1975, The Journal of allergy and clinical immunology.
[29] D. Alling,et al. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. , 1972, The New England journal of medicine.
[30] F. Rosen,et al. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. , 1971, The Journal of clinical investigation.
[31] F. Rosen,et al. Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.